The contribution of the vaccine adverse event text mining system to the classification of possible Guillain-Barré syndrome reports.

BACKGROUND We previously demonstrated that a general purpose text mining system, the Vaccine adverse event Text Mining (VaeTM) system, could be used to automatically classify reports of an-aphylaxis for post-marketing safety surveillance of vaccines. OBJECTIVE To evaluate the ability of VaeTM to classify reports to the Vaccine Adverse Event Reporting System (VAERS) of possible Guillain-Barré Syndrome (GBS). METHODS We used VaeTM to extract the key diagnostic features from the text of reports in VAERS. Then, we applied the Brighton Collaboration (BC) case definition for GBS, and an information retrieval strategy (i.e. the vector space model) to quantify the specific information that is included in the key features extracted by VaeTM and compared it with the encoded information that is already stored in VAERS as Medical Dictionary for Regulatory Activities (MedDRA) Preferred Terms (PTs). We also evaluated the contribution of the primary (diagnosis and cause of death) and secondary (second level diagnosis and symptoms) diagnostic VaeTM-based features to the total VaeTM-based information. RESULTS MedDRA captured more information and better supported the classification of reports for GBS than VaeTM (AUC: 0.904 vs. 0.777); the lower performance of VaeTM is likely due to the lack of extraction by VaeTM of specific laboratory results that are included in the BC criteria for GBS. On the other hand, the VaeTM-based classification exhibited greater specificity than the MedDRA-based approach (94.96% vs. 87.65%). Most of the VaeTM-based information was contained in the secondary diagnostic features. CONCLUSION For GBS, clinical signs and symptoms alone are not sufficient to match MedDRA coding for purposes of case classification, but are preferred if specificity is the priority.

[1]  E. Brown,et al.  The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.

[2]  Robert T. Chen,et al.  The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). , 2002, Vaccine.

[3]  Robert T. Chen,et al.  Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. , 2004, The Pediatric infectious disease journal.

[4]  Patrice Degoulet,et al.  Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach , 2005, Int. J. Medical Informatics.

[5]  Fang Liu,et al.  Concept Negation in Free Text Components of Vaccine Safety Reports , 2006, AMIA.

[6]  Fang Liu,et al.  Bmc Medical Informatics and Decision Making a Umls-based Spell Checker for Natural Language Processing in Vaccine Safety , 2006 .

[7]  David Madigan,et al.  Influence of the MedDRA® hierarchy on pharmacovigilance data mining results , 2009, Int. J. Medical Informatics.

[8]  Carol Friedman,et al.  Statistical Mining of Potential Drug Interaction Adverse Effects in FDA's Spontaneous Reporting System. , 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[9]  J. Sejvar,et al.  Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. , 2011, Vaccine.

[10]  Marianthi Markatou,et al.  Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selection , 2011, J. Am. Medical Informatics Assoc..

[11]  Martijn J Schuemie,et al.  EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. , 2011, Studies in health technology and informatics.

[12]  A. Hartzema,et al.  Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting , 2012, Journal of asthma and allergy.

[13]  Yasushi Okuno,et al.  Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system. , 2012, Biological & pharmaceutical bulletin.

[14]  P Ryan,et al.  Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis , 2012, Clinical pharmacology and therapeutics.

[15]  Robert Ball,et al.  Vaccine adverse event text mining system for extracting features from vaccine safety reports , 2012, J. Am. Medical Informatics Assoc..

[16]  Taxiarchis Botsis,et al.  Application of Information Retrieval Approaches to Case Classification in the Vaccine Adverse Event Reporting System , 2013, Drug Safety.